The Andrew McDonough B+ Foundation awarded UNC Lineberger’s Pengda Liu, PhD, assistant professor of Biochemistry and Biophysics at UNC School of Medicine, a two-year grant totaling $150,000 to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma.
Ewing sarcoma is a bone cancer that occurs mainly in children. Approximately 250 children and young adults are diagnosed with Ewing sarcoma each year in the U.S., and about half of those diagnosed will ultimately succumb to the disease, pointing to the need for better therapies.
Based in Wilmington, Delaware, the B+ Foundation was established in memory of Andrew McDonough. It has awarded millions of dollars toward research into childhood cancers and it is the largest provider of financial assistance for families of kids fighting cancer in the United States.